STAT3 and cancer: The high activation level of STAT3 under hypoxia, an oncoprotein strongly implicated in chemoresistance in cancer cells [34,53,54,55], has led us to hypothesize that STAT3 sustained the chemoresistant phenotype despite the effective experimental abrogation of HIF-1α.